https://www.selleckchem.com/pr....oducts/AR-42-HDAC-42
Infections by Carbapenem-Resistant (CRE) remain a leading cause of death in critically ill patients. Fosfomycin has been regarded as an alternative therapy for treatment of infections caused by CRE organisms. The purpose of this study is to evaluate clinical outcomes amongst patients with CRE infection who are receiving a fosfomycin dosing regimen using a Monte Carlo simulation and fosfomycin minimum inhibitory concentration (MIC). Fosfomycin MIC was defined by the E-test method. We used Fosfomycin pharmacokinetic parameters from
Like
Comment
Share
